Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Post by Hurting20on Jan 06, 2004 10:23am
262 Views
Post# 6847945

Who would you sell to?

Who would you sell to?If you did hold a large position in RBM who would you sell too? There is no volume. It was my point when Halcyon was describng short selling. You can't short a low volume stock with out shooting yourself in the foot. You drive down the price while estabishing your position. To short this you would need to be covered, which is probably what happened (if there were any shoirts) with the new issue. Coincidentally, it may be why this stock, historically, is trading near its 15 year low. No offence to anyone, but a 15 year old should know about FDA approval process rbm is now in. It isn't "a strategic thought process" One needs to ask if this info is public knowledge why won't anyone listen? Why does everyone ignore this stock now, and here is a thought what if everyone ignores this after approval is granted, for example. With little revenue and a blue haze as to how sales are going what will change. My point about insiders diving into this stock in a big way is still exremely valid. On the Radvak barometer, ie his willingness to pour his financial life into this company, he is rating this company a luke warm hold. Anoyone, as an investor, to argue against this is out to lunch. You want to convince me, phone Don and ask him why so many insiders wouldn't touch this co as an investment.
Bullboard Posts